4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-23-006457
Options or other derivatives
- Chief Business Officer acquired 220,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Derakhshan Behrad · Chief Business Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +220,000 | 220,000 | D |
Loading xslF345X05/primarydocument.xml…